386 CB6, A NOVEL GUT-SELECTIVE BCL-2 INHIBITOR, ATTENUATES INTESTINAL FIBROSIS IN MYBFIBROBLAST CELL MODELS AND THE MOUSE S. TYPHIMURIUM MODEL OF INTESTINAL FIBROSIS
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI